Brief: DanCann Pharma A/S issues warrants to the executive management team
06/04/2021 22:03
April 6 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* DANCANN PHARMA A/S -BOARD OF DIRECTORS ISSUED 1,017,147
WARRANTS
TO EXECUTIVE MANAGEMENT TEAM IN DANCANN PHARMA WITH A
SUBSCRIPTION RATE OF DKK 3.3327
Source text for Eikon: ID:nWkr54hCb7
Further company coverage: DANCAN.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874